RecruitingNCT06324539

Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease

Studying CHILD syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IRCCS Burlo Garofolo
Intervention
Diagnostic Test: Rapid Intestinal anti-TG2 Assay(diagnostic_test)
Enrollment
332 target
Eligibility
2-17 years · All sexes
Timeline
20232025

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06324539 on ClinicalTrials.gov

Other trials for CHILD syndrome

Additional recruiting or active studies for the same condition.

See all trials for CHILD syndrome

← Back to all trials